David Antonuccio, PhD

It is estimated that at least half of persons who begin antidepressant treatment will not respond to monotherapy.

The slight difference between antidepressant and placebo has been referred to as a "dirty little secret" by researchers, a secret that was believed by FDA officials to be "of no practical value."